Document Type

Article

Original Publication Date

2022

Journal/Book/Conference Title

HeartRhythm Case Reports

Volume

8

Issue

3

First Page

217

Last Page

221

DOI of Original Publication

10.1016/j.hrcr.2021.12.015

Comments

Originally published at https://doi.org/10.1016/j.hrcr.2021.12.015

Date of Submission

November 2023

Abstract

Catheter ablation is recognized as a central therapeutic option in treating patients with drug-refractory, scar-related monomorphic ventricular tachycardia (VT). Catheter ablation also has a role in selected cases of polymorphic VT (PMVT) and/or ventricular fibrillation (VF). Rarely, premature ventricular contractions (PVCs) originating from the Purkinje network can induce PMVT/VF. Although not completely elucidated, the electrophysiologic mechanisms behind this lethal arrhythmia have generally been thought to be related to abnormal automaticity and triggered activity. Ablation of the triggering PVCs can prevent VF recurrence and is potentially lifesaving

Is Part Of

VCU Internal Medicine Publications

Share

COinS